debate: clinical scenarios in aml: traditional vs targeted therapy - traditional
Published 6 years ago • 451 plays • Length 14:03Download video MP4
Download video MP3
Similar videos
-
12:59
debate: clinical scenarios in aml: traditional vs targeted therapy - targeted
-
29:07
newly diagnosed aml: hitting the right target
-
24:36
mrd in aml: what is it and what do i do about it?
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
18:29
aml treatment challenges who, when, and how
-
45:59
immune checkpoint inhibitors in solid tumours
-
2:05:35
anti-money laundering measures webinar
-
1:00:51
aml transaction monitoring tuning webinar
-
0:59
dr. mesa on racial disparities in mpn, mds, and aml clinical trials
-
20:44
update: new drugs for aml
-
52:15
acute myeloid leukemia: navigating treatment paradigm shifts and disease heterogeneity
-
22:40
treatment goals in essential thrombocythemia and polycythemia vera
-
21:46
newly approved drugs for aml
-
1:17
dr. smith on acquired resistance to targeted agents for aml
-
0:28
relatives and close associates l aml explained #52
-
23:38
why mpns transform to aml
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
20:40
cll: treatment for btki progressors
-
1:28
dr abby statler discusses restrictive criteria excluding minority patients from aml trials